Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance · FederalPipeline
Generic Drug Pathway Curriculum: From ANDA Submission to Global Reliance
Presolicitation from Food and Drug Administration, solicitation FDA-OC-2026-135574. Responses due Aug 20, 2026. NAICS 611430, No Set aside used. Listed on SAM.gov.